IRVAX | VIVIX | IRVAX / VIVIX | |
Total Expense Ratio | 0.84 | 0.04 | 2,100% |
Annual Report Gross Expense Ratio | 0.94 | 0.04 | 2,350% |
Fund Existence | 10 years | 27 years | - |
Gain YTD | -16.552 | 2.452 | -675% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266M | 189B | 0% |
Annual Yield % from dividends | 7.38 | 2.29 | 322% |
Returns for 1 year | -10.42 | 8.01 | -130% |
Returns for 3 years | 10.42 | 32.19 | 32% |
Returns for 5 years | 40.53 | 72.56 | 56% |
Returns for 10 years | 52.61 | 103.54 | 51% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THOFX | 42.08 | -0.47 | -1.10% |
Thornburg Global Opportunities R5 | |||
VVORX | 20.99 | -0.26 | -1.22% |
Invesco Value Opportunities R | |||
WMKSX | 15.73 | -0.26 | -1.63% |
WesMark Small Company Fund | |||
MIQBX | 11.77 | -0.20 | -1.67% |
Morgan Stanley Inst International Eq A | |||
RYSGX | 49.88 | -0.93 | -1.83% |
Rydex S&P SmallCap 600 Pure Growth A |